| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f677b51d501b7faa84a3a5cba20c00a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665 |
| filingDate |
2015-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aae6a528f6cdd8ac47169fe5b2664a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_500861e4447510968c3db0d648af4ea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25504f1e36be83116caf30ab388205d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00fa065fa6c3d7590ac61a018e0730b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd51680b9f31533d7552eaeb8522564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_062aa4bb90d48026713f39b4260fca1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_004cf10ddba1db70ae12e263600a1d57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc8edf5fbc4ffe970f7ea91d49e8990 |
| publicationDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9345718-B1 |
| titleOfInvention |
Phospholipid ether analogs as cancer-targeting drug vehicles |
| abstract |
The present invention is directed to therapeutic compounds capable of targeting cancer cells and cancer stem cells. The present invention is further directed to compositions comprising these therapeutic compounds and methods of treating cancer comprising administering these therapeutic compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016136290-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013720-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287353-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016228564-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535670-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385130-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9480754-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439709-B2 |
| priorityDate |
2014-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |